Articles by Tim Burroughs
AVCJ Awards 2020: Exit of the Year - Mid Cap: EMC Holdings
Taking full ownership of EMC Holdings wasn’t on Affirma Capital’s agenda, but it performed a successful pivot when the business started moving in the wrong direction
Deal focus: Olympus credit team spins out, gets OMERS backing
Olympus Capital Credit has rebranded as Orion Capital Asia, with OMERS replacing Olympus as the firm’s equity partner. The strategy is unchanged, with COVID-19 helping to drive deal flow
Carlyle-backed consortium sweetens offer for Japan Asia Group
The Carlyle Group and the chairman of Japan Asia Group (JAG) have doubled the size of their tender offer for the Tokyo-listed company following pressure from an activist investor. The chairman is contributing most of the additional equity.
CVC recruits EQT's Asia mid-market head
Martin Mok has joined CVC Capital Partners as a Hong Kong-based senior managing director after spending nearly 20 years with EQT.
Fund focus: LPs flock to Lake Bleu's late show
Lake Bleu Capital leveraged a lift in Chinese healthcare sentiment to raise $560 million for a fund that will target late-stage healthcare investments
AVCJ Awards 2020: Operational Value Add: Nexus Day Hospitals
Having formed Australia-based Nexus Day Hospitals by merging two smaller operators, Mercury Capital led a wholesale expansion and professionalization of the business
PE-owned Aadhar Housing Finance files for India IPO
Aadhar Housing Finance, an Indian affordable housing lender acquired by The Blackstone Group in 2019, is looking to raise up to INR73 billion ($1 billion) through a domestic IPO.
CITIC acquires China perfume brand
CITIC Capital has made an investment of undisclosed size in Shanghai Xiangmiao Trade, owner of Reclassified, a leading Chinese perfume and home fragrance brand.
Hopu founder backs China healthcare-focused SPAC
Fenglei Fang, founder and chairman of Chinese private equity firm Hopu Investments, is looking to raise $300 million for a special purpose acquisition company (SPAC) that will target healthcare companies with a China focus or expansion prospects in the...
China AI specialist 4Paradigm receives $700m Series D
Boyu Capital, Primavera Capital Group, and Hopu Investments have led a $700 million Series D round for 4Paradigm, a Chinese artificial intelligence (AI) technology developer that serves enterprise customers.
Q&A: Office of New York City Comptroller's Wendy Garcia
Wendy Garcia, chief diversity officer for the Office of New York City Comptroller discusses her team’s diversity and inclusion objectives and what this means for GPs seeking allocations from city’s pension funds
Vista founder calls for investment in Asia tech infrastructure
Vista Equity Partners is keen to invest in Asia’s financial technology space, but founder Robert F. Smith stressed that governments must put in place the appropriate regulatory infrastructure.
4Q analysis: Growth spurt
Technology-enabled businesses in China and India are the beneficiaries of a resurgence in growth capital deal flow; Japan is the sole stand-out in fundraising; IPOs continue to shine as overall exits struggle
Investors question eligibility for HK carried interest tax concession
Fund-of-funds and family offices could be excluded from Hong Kong’s proposed carried interest tax concession, industry participants have warned.
AVCJ Awards 2020: Fundraising of the Year - Mid Cap: Ascendent Capital Partners
A $500 million investment in Wumart is the exception rather than the rule for Ascendent Capital Partners’ third China fund, but the digital transformation theme is a constant
Fund focus: Novo Tellus closes second Southeast Asia fund at $250m
Although its second fund is considerably larger than its first, Novo Tellus Capital Partners expects to target the same kind of Southeast Asian industrial technology businesses that have succession and expansion issues
Tower Capital hits first close on Southeast Asia fund
Tower Capital, a Singapore-based GP that previously operated on a deal-by-deal basis, has achieved a first close of approximately $250 million on its first Southeast Asia-focused private equity fund.
Deal focus: Monetizing mice
ORI Capital’s 2.8x return on its investment in Kymab was in part based on helping the company make the transition from antibody-based discovery platform to drug development engine
Monument Group recruits Japan representative
Placement agent Monument Group has appointed Hiroshi Nishimuro, formerly of Morgan Stanley, as its Japan representative to lead fundraising efforts and manage GP relationships in the country.
Pathway promotes head of Hong Kong office
Simon Lau, who has led the Asian operations at fund-of-funds Pathway Capital Management since 2012, has been promoted to managing director.
Asia PE investment ends 2020 on a tear
A fourth-quarter surge in growth-stage deal-making took Asia private equity investment to $198.5 billion in 2020, comfortably surpassing the previous year’s total despite the strictures of COVID-19.
AVCJ Awards 2020: Operational Value Add: TEG
Affinity Equity Partners turned TEG from a ticketing business into a broad-based live events promoter, while simultaneously taking it from Australia-centric to global
Hillhouse founder bullish on China life sciences
Lei Zhang, founder and CEO of Hillhouse Capital, emphasized the opportunities at the nexus of life sciences and artificial intelligence-enabled supercomputing, while describing his firm as “probably the largest investor in healthcare in China.”
Australia's CPE makes $1.7b bid for Bingo Industries
A consortium led by CPE Capital has submitted a buyout offer for Bingo Industries, an Australia-based waste management and recycling company at an enterprise valuation of A$2.28 billion ($1.7 billion).